LAUSR

The coronavirus disease 2019 (COVID-19) pandemic has introduced drastic changes worldwide, particularly affecting chronic diseases such as Parkinson ’ s disease (PD). 1 Different countries have implemented variable measures to control the pandemic with a different toll on patients, which also depends on the speci fi c national healthcare. This notion inspired this cross-sectional-questionnaire-based study conducted in person between July and August 2021 and aimed at comparing the impact of forced lockdown in 60 consecutive PD outpatients followed in two movement disorders centers in North and South America. All the subjects ful fi lled the following inclusion criteria: clinical diagnosis of PD; at least one evaluation in 2019; and consent to participate. Patients were instructed to answer taking into account the changes to their care caused by the lockdown.